Akari Therapeutics
(NASDAQ:AKTX)
$1.42
-0.05[-3.40%]
At close: May 3
$1.42
0[0.00%]
After Hours: 5:38PM EDT
Peak Bio (PKBO) was merged with Akari Therapeutics (AKTX) on Wednesday, May 1, 2024

Akari Therapeutics Stock (NASDAQ:AKTX), Guidance and Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

No data available to display
Date Announced
▲▼
ticker
▲▼
Company Name
▲▼
Period
▲▼
Period Year
▲▼
Min EPS
▲▼
Max EPS
▲▼
Estimate
▲▼
Min Rev
▲▼
Max Rev
▲▼
Revenue Estimate
▲▼
Get Alert

FAQ

Q

What is the most recent guidance for Akari Therapeutics (AKTX)?

A

There have been no specific sales or earnings guidance reported for Akari Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch